Parental attention deficit disorder

Journal of Applied Philosophy

Volumn 25, Issue 3, 2008, Pages 246-261

  Fox, Dov ^a  

^a Law School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57749122407     PISSN: 02643758     EISSN: 14685930     Source Type: Journal    
DOI: 10.1111/j.1468-5930.2008.00409.x     Document Type: Article

References (43)

1. M. Small, Our Babies, Ourselves: How Biology and Culture Shape the Way We Parent (New York: Anchor Books, 1998), pp. 240-241.
2. R. Hursthouse, Beginning Lives (Oxford: Basil Blackwell, 1987), pp. 309-315.
3. J-J. Rousseau, Emile or On Education, A. Bloom. trans. (New York: Basic Books, 1978), p. 79.
4. J-J. Rousseau, Emile or On Education, A. Bloom. trans. (New York: Basic Books, 1978)., p. 38.
5. R. McDougall, ‘Acting parentally: an argument against sex selection’, Journal of Medical Ethics 3, 10 (2005): 601-605.
6. S. M. Liao, ‘The right of children to be loved’, Journal of Political Philosophy 14, 4 (2006): 420-440.
7. I. Murdoch, The Sovereignty of Good, (New York: Routledge, 1970), p. 95.
8. M. Sandel, The Case against Perfection: Ethics in the Age of Genetic Engineering (Cambridge, MA: Harvard University Press, 2007), p. 49
9. W. F. May, ‘The President’s Council on Bioethics: My take on some of its deliberations’, Perspectives in Biology and Medicine 46, 4 (2005): 229-240
10. President’s Council on Bioethics, Beyond therapy: Biotechnology and the Pursuit of Happiness (Washington, DC: U.S. Government Printing Office, 2003), p. 28.
11. J. Lachs, ‘Grand dreams of perfect people’, Cambridge Quarterly of Healthcare 9, 1 (2000): 323-329.
12. J. Zito, ‘Psychotropic practice patterns for youth: a 10-year perspective’, Archives of Pediatric and Adolescent Medicine 157, 1 (2003): 17-25.
13. L. Diller, Running on Ritalin: A Physician Reflects on Children, Society, and Performance in a Pill (New York: Bantam Books, 1998).
14. B. Finkelstein et al., ‘Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis’, Archives of Pediatrics and Adolescent Medicine 156, 1 (2002): 230-240.
15. FDA Talk Paper T03-56. 2003, ‘FDA approves humatrope for short stature’, (25. July): .
16. D. Fox, Safety, efficacy, and authenticity: The gap between ethics and law in FDA decision-making, Michigan State Law Review 4 (2005): 1135-1197.
17. D. Fox, ‘Human growth hormone and the measure of man’, The New Atlantis 1, 7 (2004): 75-87.
18. G. E. Robinson, ‘Beyond nature and nurture’, Science 304, 5669 (2004): 397-399.
19. N. Agar, Liberal Eugenics: In Defense of Human Enhancement (Oxford: Blackwell, 2004), p. 113
20. A. Caplan, ‘What’s morally wrong with eugenics?’ in P. R. Sloan (ed.) Controlling Our Destinies: Historical, Philosophical, Ethical, and Theological Perspectives on the Human Genome Project, (Notre Dame, IN: University of Notre Dame Press, 2000), p. 215
21. D. DeGrazia, ‘Enhancement technologies and human identity’, Journal of Medicine and Philosophy 30, 3 (2005): 261-283
22. J. Glover, What Sort of People Should There Be? Genetic Engineering, Brain Control, and their Impact on Our Future World, (New York: Penguin Books, 1984), p. 53
23. J. Robertson, Children of Choice: Freedom and the New Reproductive Technologies (Princeton, NJ: Princeton University Press, 1994), p. 167
24. L. Silver, Remaking Eden: How Genetic Engineering and Cloning will Transform the American Family (New York: Avon Books, 1998), p. 277.
25. D. Fox, ‘The illiberality of “liberal eugenics” ’, Ratio 20, 1 (2007): 1-25.
26. Quoted in P. Cary, ‘Rescuing children’s games from crazed coaches and parents’, U.S. New and World Report 7. June (2004): 44-53.
27. D. Patrick, ‘Let the kids play’, USA Today 26. July (2002): 1C.
28. E. Woods, Training a Tiger: A Father’s Guide to Raising a Winner in Both Golf and Life (New York: HarperCollins, 1997).
29. J. Salmon, ‘Parents who never call a timeout’, Washington Post 20. August (2000): F1.
30. S. Rice, Commercializing the American education, in Moneychanging in the Temple: The Commercialization of American Education, 2004; available at:
31. C. Haberman, ‘NYC: princesses and princes of preschool’, New York Times 19. November (2002): B1.
32. D. Fox, ‘Silver spoons and golden genes: genetic engineering and the egalitarian ethos’, American Journal of Law and Medicine 33, 4 (2007): 568-624.
33. M. Sandel, ‘The case against perfection: what’s wrong with designer children, bionic athletes, and genetic engineering’, The Atlantic Monthly 293, 4 (2004): 51-59.
34. D. Fox, ‘Luck, genes, and justice’, Journal of Law, Medicine and Ethics 35, 4 (2007): 712-726.
35. A. Sen, ‘Equality of what?’ in S. M. McMurrin (ed.) Tanner Lectures on Human Values (Cambridge: Cambridge University Press, 1980), 137, 160.
36. M. Nussbaum, Women and Human Development: The Capabilities Approach (Cambridge: Cambridge University Press, 1999), pp. 78-80.
37. S. Goering, ‘Gene therapies and the pursuit of a better human’, Cambridge Quarterly of Healthcare Ethics 9, 1 (2000): 330-341.
38. A. Sen, ‘The living standard’, in Oxford Economic Papers, 36 (1984): 74-90
39. A. Smith, An Inquiry into the Nature and Causes of the Wealth of Nations, (London, Home University Library [1776]); (Sen 1984, p. 79, citing Smith, p. 352).
40. A. Schick, ‘Autonomy and reproduction: a narrative critique’, unpublished manuscript, on file with author (2007): 1-12.
41. D. Tobey, ‘What’s really wrong with genetic enhancement: a second look at our posthuman future’, Yale Journal of Law and Technology 6 (2004): 54-155.
42. D. Fox, ‘Paying for particulars in people-to-be: commercialization, commodification, and commensurability in human reproduction, Journal of Medical Ethics 34, 3 (2008): 162-166.
43. F. Kamm, ‘Is there a problem with enhancement?’, American Journal of Bioethics 5, 3 (2005): 5-14.